tiprankstipranks
Trending News
More News >

Nutex Health price target raised to $225 from $100 at Maxim

Maxim raised the firm’s price target on Nutex Health (NUTX) to $225 from $100 and keeps a Buy rating on the shares. The company’s Q1 results were sharply above consensus as it recognized $105M in revenue from Independent Dispute Resolution arbitration, the analyst tells investors in a research note. Nutex remains on-track to open three de novo mirco-hospitals during 2025, all of which should be “second half of 2025 events”, Maxim adds.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue